Below are the most recently updated broker updates which include ratings and price targets for Ascendis Pharma A/S (NASDAQ:ASND).

02/23/2015 – Broker: Bank of America Merrill Lynch Rating: buy New Target: 27 newcoverage

02/23/2015 – Broker: Leerink Swann Rating: outperform newcoverage

02/23/2015 – Broker: Wells Fargo Rating: outperform newcoverage

The average price target from the most recent broker reports is 27.00

The stock decreased -0.50% (-0.08) during the last days session, reaching 16.08 and roughly 5077 shares were bought or sold by traders.

View other investors thoughts on Ascendis Pharma A/S with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.